about
Immunoproteomic Profiling of Antiviral Antibodies in New-Onset Type 1 Diabetes Using Protein ArraysToward defining the autoimmune microbiome for type 1 diabetesLack of correlation between the levels of soluble cytotoxic T-lymphocyte associated antigen-4 (CTLA-4) and the CT-60 genotypesNetwork for Pancreatic Organ Donors with Diabetes (nPOD): developing a tissue biobank for type 1 diabetesComplement gene variants in relation to autoantibodies to beta cell specific antigens and type 1 diabetes in the TEDDY Study.Role of Type 1 Diabetes-Associated SNPs on Risk of Autoantibody Positivity in the TEDDY Study.HLA-DRB1*15:01-DQA1*01:02-DQB1*06:02 Haplotype Protects Autoantibody-Positive Relatives From Type 1 Diabetes Throughout the Stages of Disease ProgressionInfluence of membrane CD25 stability on T lymphocyte activity: implications for immunoregulation.Assessing the utility of SELDI-TOF and model averaging for serum proteomic biomarker discovery.Culture-independent identification of gut bacteria correlated with the onset of diabetes in a rat model.Lactobacillus johnsonii N6.2 mitigates the development of type 1 diabetes in BB-DP rats.Estimating the cost of type 1 diabetes in the U.S.: a propensity score matching method.Gut microbiome metagenomics analysis suggests a functional model for the development of autoimmunity for type 1 diabetes.To screen or not to screen for pre-type 1 diabetes?Bacteroides dorei dominates gut microbiome prior to autoimmunity in Finnish children at high risk for type 1 diabetes.Prevention strategies for type 1 diabetes mellitus: current status and future directions.Type 1 diabetes islet autoantibody markers.Generation of islets of Langerhans from adult pancreatic stem cells.Cardiovascular risk factors in patients with Addison's disease: a comparative study of South African and Swedish patients.Progressive erosion of β-cell function precedes the onset of hyperglycemia in the NOD mouse model of type 1 diabetes.Reduced serum vitamin D-binding protein levels are associated with type 1 diabetes.Predictors of Progression From the Appearance of Islet Autoantibodies to Early Childhood Diabetes: The Environmental Determinants of Diabetes in the Young (TEDDY).Overview of prevention and intervention trials for type 1 diabetes.Islet replacement vs. regeneration: hope or hype?Towards a functional hypothesis relating anti-islet cell autoimmunity to the dietary impact on microbial communities and butyrate productionCombination Therapy Reverses Hyperglycemia in NOD Mice With Established Type 1 Diabetes.Acute Versus Progressive Onset of Diabetes in NOD Mice: Potential Implications for Therapeutic Interventions in Type 1 DiabetesCo-stimulation modulation with abatacept in patients with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled trial.Type 1 diabetes mellitus: etiology, presentation, and management.Type 1 diabetes through two lenses: comparing adolescent and parental perspectives with photovoice.Antigen-based therapy with glutamic acid decarboxylase (GAD) vaccine in patients with recent-onset type 1 diabetes: a randomised double-blind trial.The prediction of type 1 diabetes by multiple autoantibody levels and their incorporation into an autoantibody risk score in relatives of type 1 diabetic patientsInfluence of fecal sample storage on bacterial community diversity.Reevaluation of CMS' Competitive Bidding ProgramIncreased complement activation in human type 1 diabetes pancreata.Race, socioeconomic status, and treatment center are associated with insulin pump therapy in youth in the first year following diagnosis of type 1 diabetesInterleukin-1 antagonism in type 1 diabetes of recent onset: two multicentre, randomised, double-blind, placebo-controlled trialsVitamin D levels in subjects with and without type 1 diabetes residing in a solar rich environment.Pancreatic islet autoantibodies as predictors of type 1 diabetes in the Diabetes Prevention Trial-Type 1.9β Polymorphism of the glucocorticoid receptor gene appears to have limited impact in patients with Addison's disease.
P50
Q21972778-3664963F-60A0-486A-8567-7CB598298CB2Q24629032-17FF419B-ABCA-4994-9BC4-F13E504079DEQ24811473-4F1A9214-B947-4B68-9B00-102B14C48803Q27009104-DD6FEF49-6322-426D-86A1-E58184F7AD87Q28601170-404F1481-39DB-4D4D-A4F9-47928916A63CQ30301275-C7A53034-9CEA-4227-BEEA-D47448D0B799Q30732418-2EA2B923-C1D3-4E4E-8F42-F6E103480BD0Q30946446-451FCBDD-9B6A-4884-B1C5-9183E0B45FAFQ33263211-7D049E7C-8F2B-4247-BD75-AA1EB39BA788Q33410248-CC9E8325-DF51-4C1B-8F98-148CCAD76931Q33576806-65CA60EA-D72E-425C-B6B8-633DE73924FAQ33634067-EDF9D22F-6A5C-44B1-9FBF-2CAE2D9AA6CFQ34063601-4CA7C928-4709-4F9B-9E51-8C13755B7E4CQ34616308-174105EB-3883-4B8F-A39C-D9DBF6248D25Q34668698-EC2781DD-634C-4597-A8DB-FADAA2E61FAAQ35047999-003C09C2-8539-478E-BCFB-0BBF691C4156Q35076755-D68F8514-FF29-4BAC-91CA-D292B04BE8C6Q35092645-8E44265E-4FA6-425E-8376-C73A72353823Q35112841-41C644CD-5CD8-4566-A0D0-02A5B26A2610Q35123531-DDF9E7FD-DDF2-4FAD-8040-AF297DCADEBFQ35227135-B959833D-ED28-48D3-9721-7C6417D7868BQ35531906-ED685ED3-D817-4055-8246-F9CBFB2B4F37Q35583872-751358FC-7272-4979-B4EB-C65E6AC5FFFDQ35985305-539E453C-25D1-4ECF-A0E1-4B27AC812516Q35999067-92E8C0C1-3C17-44FB-BE65-C093A6DC92E7Q36186226-848BD988-C9C0-4A44-BAC3-158AFF4826DDQ36186271-4F80C7D3-1646-4450-BDDE-66BDB9F54851Q36292592-0633D29C-B611-4250-A4AA-8D2E592D62BCQ36318729-40380F5F-6153-409C-97FF-06A2991EEA27Q36481695-0BE5E4D2-2B90-4767-B511-E8DE3754E3EAQ36632019-95105120-8E1B-43DC-B278-0B7C76593608Q37106456-0B4EFEC1-CC3C-4442-86D9-1122F517DE14Q37189659-AC615C94-AC46-455F-9F4E-40A76B6B0D73Q37237436-72F2BD6B-1A64-4B9A-942D-3A5540041094Q37278134-38DFBCD9-E538-49D3-93CA-70F4A6F5AF9CQ37280760-83F8BA67-35AB-4E86-936F-2A1B21655048Q37307777-27030AC3-E710-4A5D-B999-477A2D5FF5A5Q37400808-7BC1B996-D92F-4C26-86A2-8D68049F0B31Q37437161-7A9E3520-BEA8-4E30-A23A-CADD310DDDB2Q37510074-2EF424EA-811E-4308-8399-8232AF957BA3
P50
description
researcher
@en
wetenschapper
@nl
name
Desmond Schatz
@en
Desmond Schatz
@nl
type
label
Desmond Schatz
@en
Desmond Schatz
@nl
prefLabel
Desmond Schatz
@en
Desmond Schatz
@nl
P31
P496
0000-0002-1044-5762